Exponent, Inc. (EXPO)
NASDAQ: EXPO · Real-Time Price · USD
58.32
-0.10 (-0.17%)
May 29, 2026, 4:00 PM EDT - Market closed

Company Description

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally.

The company operates in two segments, Engineering and Other Scientific, and Environmental and Health.

It provides services in the areas of biomechanics, biomedical engineering and sciences, civil and structural engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, metallurgical and corrosion engineering polymer and chemistry, thermal sciences, and vehicle engineering.

The company also offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences.

In addition, it provides proactive and reactive product safety, litigation support, and technical, regulatory services.

It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors.

The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998.

The company was founded in 1967 and is headquartered in Menlo Park, California.

Exponent, Inc.
Exponent logo
CountryUnited States
Founded1967
IPO DateAug 17, 1990
IndustryEngineering & Construction
SectorIndustrials
Employees1,013
CEOCatherine Corrigan

Contact Details

Address:
149 Commonwealth Drive
Menlo Park, California 94025
United States
Phone650 326 9400
Websiteexponent.com

Stock Details

Ticker SymbolEXPO
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearFebruary - January
Reporting CurrencyUSD
CIK Code0000851520
CUSIP Number30214U102
ISIN NumberUS30214U1025
Employer ID77-0218904
SIC Code8742

Key Executives

NamePosition
Dr. Catherine Ford Corrigan P.E., Ph.D.Chief Executive Officer and Director
Richard L. Schlenker Jr.Executive Vice President and Corporate Secretary
Dr. Maureen T. F. Reitman F.S.P.E., P.E., Sc.D.Group Vice President
Dr. Joseph Rakow Ph.D.Group Vice President
Dr. Joseph Sala Ph.D.Group Vice President
Dr. John D. Pye P.E., Ph.D.President
Dr. Bernard Ross P.E., Ph.D.Co-Founder, Chairman Emeritus and Principal Engineer
Eric R. AndersonChief Financial Officer
Dr. Subbaiah V. Malladi P.E., Ph.D.Chief Technology Officer and Principal Engineer
Gina FlynnVice President of Legal and General Counsel

Latest SEC Filings

DateTypeTitle
May 26, 2026144Filing
May 19, 2026144Filing
May 15, 2026144Filing
May 14, 2026SCHEDULE 13G/AFiling
May 13, 2026144Filing
May 13, 2026144Filing
May 8, 202610-QQuarterly Report
Apr 30, 20268-KCurrent Report
Apr 29, 2026SCHEDULE 13GFiling
Apr 29, 2026SCHEDULE 13GFiling